Skip to main content
PLOS One logoLink to PLOS One
. 2026 Sep 30;21(9):e0355986. doi: 10.1371/journal.pone.0355986

The moderating role of impulsivity in the association between sexual abuse and substance use frequency across countries, gender identities, and sexual orientations

Damla E Aksen 1,*, Marc N Potenza 2,3,4, Sarah D Lichenstein 5, Léna Nagy 6,7, Shane W Kraus 8, Joël Billieux 9,10, Loïs Fournier 9, Zsolt Demetrovics 11,7,12, Mónika Koós 13; International Sex Survey Consortium, Beáta Bőthe 14,15
Editor: Emily Lund16
PMCID: PMC13626376  PMID: 42814680

Abstract

This study examined how impulsivity moderates the relationship between sexual abuse and substance use frequency in a large international sample. Participants (N = 64,472) completed the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST-11), the UPPS-P Impulsive Behavior Scale, and sexual abuse measures through the International Sex Survey. Structural equation models tested associations between childhood sexual abuse (CSA), adolescent/adult sexual abuse (AASA), and combined exposure with substance use frequency, and explored moderation by impulsivity across gender identity, sexual orientation, and country. AASA and CSA+AASA were consistently associated with higher substance use frequency, while CSA alone showed weaker or inconsistent associations across groups. Urgency and premeditation facets of impulsivity moderated these associations, particularly among sexual and gender minority individuals. Country-level differences indicated cultural and contextual variation in how impulsivity interacts with trauma to influence substance use. Findings underscore the need for targeted, culturally responsive interventions addressing impulsivity in the aftermath of sexual trauma.


Sexual abuse is a robust and well-documented risk factor for substance use and misuse. Individuals who experience sexual abuse during childhood or adolescence are more likely to engage in problematic substance use in adulthood, including heightened risk for dependence, polysubstance use, and earlier initiation of use [1,2]. However, not all survivors of sexual abuse follow this course, suggesting that individual differences, including personality features, are susceptible to moderate associations between trauma and substance-related outcomes. Identifying factors that may influence this heterogeneity is important for improving clinical risk assessment as well as prevention and treatment approaches [3,4].

Impulsivity is a multidimensional construct that contributes importantly to the etiology and maintenance of substance use disorders. Globally defined as a predisposition toward rapid, unplanned reactions to internal or external stimuli with diminished regard to negative consequences [5], impulsivity has been repeatedly associated with more severe use of substances and poor treatment engagement [6,7]. Over the past decades, the UPPS-P Impulsive Behavior Model [8,9] has become a dominant framework to conceptualize impulsivity traits, which has gained traction in both research and clinical practice. Its corresponding assessment tool, the UPPS-P Impulsive Behavior Scale, assesses five distinct aspects of impulsivity: lack of premeditation, lack of perseverance, sensation seeking, negative urgency, and positive urgency [8,9]. These facets exhibit unique associations with various psychopathological symptoms and problematic behaviors, including substance use and misuse, as well as trauma-related behaviors [10,11]. Mood dysregulation and impulsivity have also been found to jointly mediate relationships between early adversity and subsequent substance use [12].

As urgency captures the tendency to act rashly in conditions of intense negative or positive emotion, it may be specifically relevant in trauma-exposed populations, particularly with regard to the facet of negative urgency [3,13,14]. Urgency may potentiate the risk of externalizing behaviors, including substance use, among trauma survivors [3]. Impulsivity may strengthen the relationship between emotional distress and substance use across adolescence [15], suggesting that timing and trajectory may be important considerations. Such relationships resonate with research identifying PTSD symptoms and impulsivity as key contributors to problematic substance use in adolescents with adverse childhood experiences [16]. Yet, while a growing body of literature has examined impulsivity as a mediator or moderator of trauma outcomes, few studies have tested whether specific impulsivity domains interact with distinct forms of sexual abuse, namely, childhood sexual abuse (CSA) and adolescent/adult sexual abuse (AASA) to predict substance use. Bearing in mind that impulsivity is a multi-dimensional construct, tackling the specific role of its various facets is warranted to tailor and improve prevention strategies and treatment options. Moreover, despite increasing recognition of the importance of culturally and demographically responsive research [17], existing studies have rarely considered how such moderation effects may vary across key social identity groups.

Gender identity, sexual orientation, and national context each contribute to shape both trauma exposure and substance use patterns [18,19]. Gender-Minority individuals, for example, report higher rates of both sexual victimization and substance use, yet remain underrepresented in the literature on trauma and behavioral risk [19,20]. Similarly, substance use frequency patterns differ by sexual orientation and vary cross-nationally due to sociopolitical and economic conditions that influence both the prevalence and the meaning of substance use and misuse [21–23]. Understanding whether and how the interaction between trauma and impulsivity facets differs across these groups is important to foster effective and equitable prevention and intervention.

Aims and objectives

The present study examined impulsivity as a moderating factor in the relationship between sexual abuse history and substance use frequency in a large international sample. The study was preregistered to examine both alcohol- and drug-related outcomes using the Alcohol Use Disorders Identification Test (AUDIT) and the ASSIST-11 (https://osf.io/v3mgx); however, during manuscript preparation, we determined that these measures capture conceptually distinct constructs, as the ASSIST-11 assesses only frequency of substance use whereas the AUDIT assesses both alcohol use and related consequences (e.g., problems, dependence symptoms). Since combining non-comparable dependent variables would reduce interpretability and conceptual clarity, we presented the ASSIST-11-based substance use findings in the current manuscript and report the AUDIT-based alcohol misuse findings in a separate paper. Using latent variable interaction models and the ASSIST-11, we investigated whether UPPS-P impulsivity domains interacted with distinct forms of sexual abuse to statistically predict substance use frequency, and whether these associations varied across gender identity, sexual orientation, and country. By identifying how individual tendencies and social-contextual factors relate to substance use as a function of different sexual abuse contexts, this study aimed to provide a more comprehensive understanding of trauma-related vulnerability

We first evaluated the extent to which different forms of sexual abuse, childhood sexual abuse (CSA), adolescent/adult sexual abuse (AASA), and combined lifetime exposure (CSA+AASA), were associated with patterns of substance use, as assessed by the ASSIST-11. We anticipated that each form of abuse would show significant, positive associations with greater substance involvement.

Next, we examined whether these associations varied based on demographic characteristics, including gender identity, sexual orientation, and country. Drawing on the minority stress theory [24], we hypothesized that sexual and gender minority (SGM) individuals would exhibit stronger associations between sexual abuse and substance use frequency than their cisgender, heterosexual counterparts, given likely heightened exposure to social stressors and cumulative adversity [25].

We also tested the moderating role of impulsivity, particularly urgency-related facets, positive and negative urgency, in abuse/substance-use associations [7,9,26]. Specifically, we hypothesized that individuals with higher levels of positive and negative urgency would show stronger associations between sexual abuse and substance use frequency.

Beyond these primary analyses, we explored whether other impulsivity domains, namely, lack of premeditation, lack of perseverance, and sensation seeking, also moderated these associations across gender-identity and sexual-orientation groups, as well as exploring variation in relationships related to abuse timing (CSA, AASA, or both). Finally, we examined whether the moderating role of impulsivity domains differed across national contexts, with the goal of providing a more globally nuanced understanding of the interplay between sexual abuse, impulsivity, and substance use frequency.

Methods

Procedure

Data for the present study were drawn from a completed dataset. The lead author did not have full access to the data prior to preregistration. This project is part of the International Sex Survey (ISS), a multilingual, cross-sectional study conducted across 42 countries and designed to collect self-report data from community-dwelling adults (preregistration link; see Bothe et al., 2021 for the full study protocol). Participant recruitment occurred between October 2021 and May 2022 through various online advertisements. Inclusion criteria required participants to be at or above the legal minimum age of consent in their respective countries (e.g., 18 years in Canada, 20 years in Taiwan); no minors were included. All participants provided informed consent electronically prior to participation. Eligible individuals completed a 25–45-minute anonymous questionnaire administered via Qualtrics. No financial compensation was offered; however, participants could opt to direct a $0.50 donation to one of several international non-profit organizations focused on sexuality and sexual health (donations were capped at $1,000 total). Detailed information about participating countries, translation processes, survey procedures, and eligibility standards is available in the study protocol [27]. Ethics approval for the International Sex Survey (ISS) was obtained from the relevant institutional review boards (IRBs) and ethics committees across all participating sites prior to data collection. In Canada, ethics approval was granted by the Comité d’éthique de la recherche of the Université du Québec à Trois-Rivières and the Comité d’éthique de la recherche en éducation et en psychologie of the Université de Montréal. All participants provided written informed consent electronically prior to completing the survey. A complete list of ethics approvals by country is available at the OSF project page (link to ethics approvals). To promote open science and transparency, a list of all resulting publications and conference presentations is maintained on the OSF project page (publication link; presentation link).

Sample

Following data cleaning procedures (see link for details), the final ISS dataset comprises responses from 82,243 individuals across 42 countries. For the current analysis, we included only those participants who completed the Sexual Abuse History Questionnaire (SAHQ), the short version of the UPPS-P Impulsive Behavior Scale (SUPPS-P), and the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST-11), and who were from countries where these instruments demonstrated acceptable psychometric properties. Although the SAHQ and ASSIST-11 showed robust validity and reliability across most participating nations, the SUPPS-P was found to meet psychometric standards in only 26 countries [28–31]. As a result, all analyses for the current study were limited to data from these 26 countries: Australia, Austria, Belgium, Canada, Chile, Colombia, Croatia, France, Germany, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, New Zealand, North Macedonia, Peru, Poland, Portugal, South Africa, South Korea, Spain, Switzerland, the United Kingdom, and the United States [28].

The final sample for the current analyses consisted of N = 64,472 participants across 26 countries (see Table 1). Gender identity was grouped into three categories: cisgender men (n = 23,004), cisgender women (n = 38,136), and gender-minority individuals (n = 3,332). Participants’ sexual orientation was categorized as heterosexual (n = 43,343), gay or lesbian (n = 3,302), and other sexual orientations (n = 17,802). This demographically and geographically diverse dataset offers a unique opportunity for examining how sexual abuse history, impulsivity domains, and substance use frequency intersect across different populations. Summary statistics for key variables are reported in Table 2.

Table 1. Sociodemographic Distribution of the Sample (N = 64,472).

Category Group n
Country Australia 639
Austria 746
Belgium 644
Canada 2541
Chile 1173
Colombia 1913
Croatia 2390
France 1706
Germany 3271
Hungary 11200
Ireland 1702
Israel 1334
Italy 2401
Malaysia 1170
Mexico 2137
New Zealand 2834
North Macedonia 1251
Peru 2398
Poland 9892
Portugal 2262
South Africa 1849
South Korea 1464
Spain 2327
Switzerland 1144
United Kingdom 1412
United States 2398
Gender Identity Cisgender Men 23004
Cisgender Women 38136
Gender Diverse 3332
Sexual Orientation Gay/Lesbian 3302
Heterosexual 43343
Other 17802

Table 2. Descriptive Statistics (N = 64,472).

Variable M SD Min Max
ASSIST-11 3.36 3.36 0 37
UPPS_PR 7.19 2.18 4 16
UPPS_PE 7.72 2.48 4 16
UPPS_SE 9.76 2.69 4 16
UPPS_PU 9.44 2.55 4 16
UPPS_NU 9.06 2.82 4 16

Note. SD = Standard deviation; ASSIST-11 = total score for the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST-11), ranging from 0 to 40, with higher scores reflecting greater substance involvement across 10 substances in the past three months; UPPS_PR = total score for the UPPS-P Lack of Premeditation subscale (4 items, range: 4–16); UPPS_PE = total score for the UPPS-P Lack of Perseverance subscale (4 items, range: 4–16); UPPS_SE = total score for the UPPS-P Sensation Seeking subscale (4 items, range: 4–16); UPPS_PU = total score for the UPPS-P Positive Urgency subscale (4 items, range: 4–16); UPPS_NU = total score for the UPPS-P Negative Urgency subscale (4 items, range: 4–16). For all UPPS-P subscales, higher scores indicate greater impulsivity on that dimension. All subscales are from the Short version of the UPPS-P Impulsive Behavior Scale (SUPPS-P; Billieux et al., 2012), rated on a 4-point Likert scale (1 = strongly agree to 4 = strongly disagree), with relevant items reverse-scored so that higher scores uniformly reflect higher impulsivity.

Measures

All included measures and translations can be found at https://osf.io/jcz96/files/osfstorage

Sociodemographic characteristics.

Participants provided information on key demographic variables, including age, gender identity, sexual orientation, education level, and country of residence. Country of residence was determined via a single item at the beginning of the survey. Age was assessed by asking participants to report their current age in years. Gender identity was derived from multiple questions capturing sex assigned at birth and current gender identity, and responses were categorized into three groups for analysis: cisgender men, cisgender women, and gender minority individuals. The original preregistration included six distinct gender-identity groups; for the final analysis, these were consolidated into three broader categories to enable meaningful statistical comparisons and maintain adequate sample sizes within each group. Sexual orientation was similarly grouped into three categories: heterosexual, gay or lesbian, and other sexual orientations (including bisexual, pansexual, asexual, queer, and other non-heterosexual, non-gay/lesbian identities). This grouping was necessary to maintain adequate cell sizes for stable structural equation modeling; the original preregistration specified eight sexual orientation categories, but several had insufficient sample sizes for reliable model estimation.

Sexual abuse history questionnaire (SAHQ; [32]).

The SAHQ [31,32] is a self-report instrument used to evaluate experiences of sexual abuse during different developmental periods. The measure includes six dichotomous (0 = “no,” 1 = “yes”) items, such as " Has anyone ever exposed the sex organs of their body to you when you did not want it?” and " Has anyone ever threatened to have sex with you when you did not want it?” Participants were categorized into three groups based on their reported abuse history: [1] CSA only, defined as abuse occurring at age 13 or younger; [2] AASA only, defined as abuse beginning at age 14 or older; and [3] CSA + AASA, reflecting abuse reported in both childhood and adolescence/adulthood. The SAHQ demonstrates solid psychometric properties, including convergent validity, test-retest reliability, internal consistency, and measurement invariance across gender-identity-, sexual-orientation-, and country-based contexts [31].

Short version of the UPPS-P Impulsive Behavior Scale (SUPPS-P; [33]).

The SUPPS-P [28,33] is a 20-item short form of the UPPS-P Impulsive Behavior Scale assessing five facets of impulsivity, with four items per subscale: lack of premeditation (e.g., ‘I usually think carefully before doing anything’ [reverse-coded]), lack of perseverance (e.g., ‘I finish what I start’ [reverse-coded]), sensation seeking (e.g., ‘I welcome new and exciting experiences and sensations, even if they are a little frightening or unconventional’), negative urgency (e.g., ‘When I feel bad, I often do things I later regret’), and positive urgency (e.g., ‘When I'm in a great mood, I tend to get carried away easily’). Responses are recorded on a 4-point Likert scale… Items for lack of premeditation and lack of perseverance are reverse coded such that higher scores on all subscales uniformly reflect higher impulsivity. Subscale scores range from 4 to 16. The SUPPS-P has demonstrated good convergent validity with established impulsivity measures (e.g., Barratt Impulsiveness Scale, BIS-11), as well as high internal consistency and test-retest reliability [28,33,34].

Alcohol, smoking, and substance involvement screening test (ASSIST-11; [35]).

The ASSIST-11 [35] is an 11-item instrument developed by the World Health Organization to assess substance involvement across a range of substances. Participants are asked how often they have used substances such as alcohol, tobacco, cannabis, cocaine, and opioids in the past three months (e.g., “In the past three months, how often have you used cannabis?”). Responses are rated on a 5-point Likert scale from 0 (never) to 4 (daily or almost daily). The final item prompts participants to write in any “other” substances not listed. Higher scores reflect greater levels of substance involvement. The ASSIST-11 has demonstrated strong cross-cultural reliability, convergent validity [36], and internal consistency [30,37].

Statistical analyses

To address the study’s hypotheses and exploratory aims, we first evaluated measurement invariance for CSA, AASA, and ASSIST-11 variables across country, gender-identity, and sexual-orientation groups. Establishing measurement invariance is essential for confirming that these constructs are interpreted consistently across different groups, enabling valid group comparisons. Given the ordinal nature of the data, we used Diagonally Weighted Least Squares (DWLS) estimation. We tested three levels of invariance: (1) configural invariance, assessing whether the underlying factor structure is consistent across groups; (2) metric invariance, evaluating whether factor loadings are equivalent; and (3) scalar invariance, which tests equality of both factor loadings and item thresholds.

Model fit was assessed using the Comparative Fit Index (CFI), Tucker-Lewis Index (TLI), and Root Mean Square Error of Approximation (RMSEA), following guidelines by Kline (2016). Acceptable model fit was indicated by CFI and TLI ≥ 0.900 and RMSEA ≤ 0.080; optimal fit was defined as CFI and TLI ≥ 0.950 and RMSEA ≤ 0.050 [38–42]. Invariance was judged based on changes in model fit: a CFI decrease ≤ 0.010 and RMSEA increase ≤ 0.015 indicated invariance (Chen, 2007). For comparisons across larger groupings (e.g., > 10 groups), more relaxed criteria were applied, with CFI changes ≤ 0.020 and RMSEA changes ≤ 0.030 [43,44].

Next, we used linear regression models to examine bivariate associations between sexual abuse history (CSA, AASA, CSA + AASA, with no history of sexual victimization as the referent) and substance use frequency (ASSIST-11 scores). Three regression models were estimated with ASSIST-11 as the dependent variable and CSA, AASA, and CSA + AASA as predictors.

We then conducted multi-group structural equation modeling (SEM) to investigate whether the strength of these associations varied across gender-identity and sexual-orientation groups. We compared constrained and unconstrained models to determine if the paths significantly differed by group.

Finally, latent variable interaction models were tested to assess whether impulsivity facets moderated the relationship between sexual abuse history and substance use in the total sample. Interaction terms between each SUPPS-P subscales (e.g., lack of premeditation, sensation seeking) and CSA, AASA, and CSA + AASA were included as predictors of ASSIST-11 scores. These models were first estimated in the total sample and then stratified by gender-identity, sexual-orientation, and country groups to examine whether moderation effects varied across demographic contexts. Where significant interactions were identified, simple slopes analyses were conducted at −1 SD, mean, and +1 SD levels of the moderator to interpret the nature of moderation.

Results

Descriptive analyses

The mean ASSIST-11 score was 3.36 (SD = 3.36, range = 0–37). Of the participants, 11.24% had a history of CSA only, 27% had a history of AASA only, and 18.57% had a history of both CSA and AASA (CSA + AASA).

Measurement invariance testing and group comparison.

We conducted a series of measurement invariance tests for CSA, AASA, and ASSIST-11 across 26 countries, three sexual-orientation groups, and three gender-identity groups. Due to convergence issues, country-level analyses were divided into two subsets of 13 countries each. Both country-based groups demonstrated good configural fit, but full metric invariance was not achieved. After freeing a small number of item loadings (CSA items 2–3, ASSIST items 2–9 across subsets), partial metric invariance was established. Similarly, partial scalar invariance was required in several cases, achieved by freeing a limited number of intercepts (e.g., CSA items 1–2, AASA item 1, and ASSIST item 2). The number of freed parameters was small relative to the total, supporting the plausibility and parsimony of the partial invariance models. Mean comparisons using Kruskal-Wallis tests revealed significant country-level differences in ASSIST-11 scores, with the highest scores observed in Croatia, New Zealand, and Switzerland. Across sexual-orientation groups, configural and metric invariance were supported, but partial scalar invariance was required. Kruskal-Wallis tests indicated significant group differences, with highest ASSIST-11 scores among individuals identifying with other sexual orientations. For gender identity, full configural, metric, and scalar invariance were achieved. Kruskal-Wallis tests showed significant differences, with gender-minority individuals reporting the highest ASSIST-11 scores. Full fit indices and item-level details are provided in S1 Text and S2 Table.

Regression analyses

We conducted a series of linear regressions in the SEM framework to examine the associations between sexual abuse history (CSA, AASA, and CSA+AASA, with no history of sexual victimization as the referent) and substance use frequency (ASSIST-11; Table 3). CSA, AASA, and CSA+AASA were each positively associated with substance use frequency, although the variance explained by the models was small (R² < .001). When examining differences by gender identity (Table 4), CSA was associated with lower substance use frequency among cisgender women and gender-minority individuals. In contrast, AASA was associated with higher substance use frequency for cisgender men and cisgender women, but not for gender-minority individuals. CSA+AASA was associated with consistently higher substance use frequency across all gender-identity groups compared to individuals with no history of sexual abuse. Analyses by sexual orientation (Table 5) showed a similar pattern. CSA was associated with lower levels of substance use frequency among all three sexual-orientation groups. AASA was associated with higher substance use frequency across all sexual-orientation groups. Similarly, CSA+AASA was associated with higher substance use frequency across all groups.

Table 3. Parameter Estimates from Structural Equation Models Predicting ASSIST-11 Scores.

Model B β SE p R²
CSA on ASSIST-11 54.86 0.01 32.96 0.096 <.001
AASA on ASSIST-11 70.38 0.01 24.38 0.004 <.001
CSA + AASA on ASSIST-11 6.06 0.001 27.38 0.82 <.001

Note. CSA = Childhood Sexual Abuse; AASA = Adult Sexual Abuse; ASSIST-11 = Alcohol, Smoking and Substance Involvement Screening Test.

Table 4. Structural Equation Models Predicting ASSIST-11 Scores Across Gender-Identity Groups.

Predictor Group B β SE p
CSA
Cisgender Men −0.10 −0.01 0.08 .160
Cisgender Women −0.52 −0.05 0.06 <.001
Gender-Minority Individuals −0.92 −0.07 0.23 <.001
AASA
Cisgender Men 0.82 0.09 0.06 <.001
Cisgender Women 0.63 0.09 0.04 <.001
Gender-Minority Individuals 0.47 0.05 0.16 .003
CSA + AASA
Cisgender Men 0.79 0.06 0.09 <.001
Cisgender Women 0.76 0.10 0.04 <.001
Gender-Minority Individuals 1.29 0.15 0.15 <.001

Note. CSA = Childhood Sexual Abuse; AASA = Adult Sexual Abuse; CSA+AASA = Lifetime Sexual Abuse; ASSIST-11 = Alcohol, Smoking and Substance Involvement Screening Test

Table 5. Structural Equation Models Predicting ASSIST-11 Scores Across Sexual-Orientation Groups.

Predictor Group B β SE p
CSA
Heterosexual −0.28 −0.03 0.05 <.001
Gay/Lesbian −0.51 −0.04 0.21 .017
Other Sexual Orientations −0.63 −0.05 0.09 <.001
AASA
Heterosexual 0.53 0.07 0.04 <.001
Gay/Lesbian 0.83 0.10 0.15 <.001
Other Sexual Orientations 0.60 0.08 0.06 <.001
CSA + AASA
Heterosexual 0.48 0.05 0.04 <.001
Gay/Lesbian 0.64 0.07 0.17 <.001
Other Sexual Orientations 0.88 0.11 0.06 <.001

Note. CSA = Childhood Sexual Abuse; AASA = Adult Sexual Abuse; ASSIST-11 = Alcohol, Smoking and Substance Involvement Screening Test.

Analyses stratified by country (Table 6) revealed that patterns varied across geographic contexts. CSA was associated with lower levels of substance use frequency in a subset of countries, including Peru, South Africa, and United States of America, although most associations across countries were non-significant. Notably, AASA was associated with higher levels of substance use frequency in almost all countries except for Belgium, Mexico, and Peru. CSA+AASA was generally associated with higher substance use frequency across all countries except for Belgium and United Kingdom.

Table 6. Structural Equation Models Predicting ASSIST-11 Scores Across Country Groups.

Predictor Group B β SE p
CSA
Australia −0.60 −0.05 0.55 .280
Austria 0.21 0.02 0.44 .630
Belgium 0.74 0.07 0.44 .095
Canada −0.55 −0.04 0.26 .033
Colombia 0.03 0.003 0.19 .870
Croatia −0.12 −0.01 0.29 .680
France 0.20 0.02 0.27 .470
Germany 0.05 0.01 0.16 .740
Hungary −0.05 −0.004 0.11 .640
Ireland −0.99 −0.08 0.34 .004
Israel −0.40 −0.04 0.32 .210
Italy −0.11 −0.01 0.25 .670
Malaysia −0.06 −0.01 0.22 .780
Mexico −0.27 −0.04 0.17 .110
New Zealand −0.28 −0.02 0.27 .300
North Macedonia −0.11 −0.01 0.45 .810
Peru −0.47 −0.07 0.14 .001
Poland −0.27 −0.03 0.11 .012
Portugal −0.32 −0.03 0.23 .160
South Africa −0.60 −0.05 0.28 .033
South Korea −0.17 −0.03 0.18 .350
Spain −0.28 −0.02 0.25 .280
Switzerland −0.66 −0.06 0.33 .048
United Kingdom −0.43 −0.03 0.36 .230
United States −0.70 −0.06 0.27 .009
Chile −0.16 −0.02 0.30 .590
AASA
Australia 0.86 0.10 0.35 .014
Austria 0.86 0.11 0.29 .003
Belgium −0.26 −0.04 0.30 .390
Canada 0.40 0.05 0.15 .010
Colombia 0.58 0.07 0.20 .004
Croatia 0.63 0.08 0.18 <.001
France 0.47 0.06 0.20 .016
Germany 0.43 0.06 0.12 <.001
Hungary 0.60 0.08 0.08 <.001
Ireland 0.57 0.08 0.20 .004
Israel 0.55 0.07 0.24 .019
Italy 0.44 0.06 0.17 .009
Malaysia 0.77 0.13 0.17 <.001
Mexico 0.26 0.04 0.16 .099
New Zealand 0.39 0.05 0.16 .016
North Macedonia 0.95 0.10 0.28 .001
Peru 0.13 0.02 0.15 .360
Poland 0.32 0.05 0.07 <.001
Portugal 0.65 0.09 0.16 <.001
South Africa 0.65 0.08 0.20 .001
South Korea 0.53 0.08 0.18 .003
Spain 0.93 0.13 0.15 <.001
Switzerland 0.67 0.09 0.22 .002
United Kingdom 0.82 0.11 0.21 <.001
United States 0.55 0.07 0.17 .002
Chile 0.87 0.11 0.24 <.001
CSA + AASA
Australia 1.22 0.14 0.37 <.001
Austria 1.07 0.11 0.36 .003
Belgium 0.67 0.08 0.36 .065
Canada 0.83 0.10 0.18 <.001
Colombia 0.93 0.11 0.20 <.001
Croatia 0.86 0.09 0.22 <.001
France 0.58 0.07 0.21 .007
Germany 0.47 0.06 0.15 .001
Hungary 0.67 0.07 0.10 <.001
Ireland 0.86 0.10 0.22 <.001
Israel 1.07 0.12 0.26 <.001
Italy 0.42 0.04 0.21 .045
Malaysia 0.60 0.10 0.19 .002
Mexico 0.75 0.12 0.15 <.001
New Zealand 1.02 0.12 0.17 <.001
North Macedonia 1.56 0.13 0.36 <.001
Peru 0.82 0.13 0.13 <.001
Poland 0.62 0.08 0.08 <.001
Portugal 1.06 0.13 0.18 <.001
South Africa 1.02 0.11 0.23 <.001
South Korea 0.90 0.13 0.19 <.001
Spain 0.48 0.05 0.21 .020
Switzerland 0.91 0.10 0.27 .001
United Kingdom 0.23 0.03 0.23 .310
United States 1.31 0.16 0.17 <.001
Chile 1.13 0.13 0.27 <.001

Note. CSA = Childhood Sexual Abuse; AASA = Adult Sexual Abuse; CSA+AASA = Lifetime Sexual Abuse; ASSIST-11 = Alcohol, Smoking and Substance Involvement Screening Test.

Regression analyses by impulsivity domains

We conducted a series of linear regressions in the SEM framework and simple slopes analyses to examine whether impulsivity domains moderated the associations between sexual abuse history and substance use frequency. Results are presented in S3 Table.

Consistent with our hypotheses, both positive and negative urgency significantly moderated the relationship between CSA and substance use frequency (positive urgency: B = −0.04, p = .015; negative urgency: B = −0.05, p = .002), such that higher levels of urgency were associated with a stronger positive association. For AASA, only negative urgency emerged as a significant moderator (B = 0.03, p = .015). In the case of CSA+AASA, both positive (B = 0.10, p < .001) and negative urgency (B = 0.06, p < .001) again significantly amplified the association with substance use frequency.

In exploratory analyses, we also examined whether other impulsivity domains moderated abuse/substance-use relationships (see S4 Table). For CSA, lack of premeditation (B = −0.04, p = .035), lack of perseverance (B = −0.06, p = .001), and sensation seeking (B = −0.04, p = .006) all emerged as significant moderators. These effects indicated that higher impulsivity scores were associated with stronger abuse/substance-use associations. These domains did not significantly moderate the AASA/substance-use link (ps > .05), but all three significantly moderated the CSA+AASA association: lack of premeditation (B = 0.07, p < .001), lack of perseverance (B = 0.07, p < .001), and sensation seeking (B = 0.08, p < .001).

Simple slopes analyses across all significant interactions revealed that higher levels of impulsivity were associated with stronger associations between sexual abuse and substance use frequency.

Gender-identity groups.

Across gender-identity groups, significant moderation effects were most consistently observed among cisgender women and gender-minority individuals (see Table 4). Among cisgender women, all impulsivity domains moderated the association between CSA and substance use frequency, with higher impulsivity associated with more negative associations. For CSA combined with AASA, higher impulsivity across all domains was associated with more positive associations. No significant moderation effects were observed for AASA. Among cisgender men, effects were largely non-significant or inconsistent. Gender-minority individuals showed a mixed pattern, with negative associations observed for CSA and positive associations for CSA+AASA at higher levels of impulsivity.

Sexual-orientation groups.

Across sexual-orientation groups, significant moderation effects were most consistently observed among individuals identifying as gay or lesbian and those identifying with other sexual orientations (see Table 5). For CSA, higher impulsivity was generally associated with more negative associations among individuals identifying as gay or lesbian and those with other orientations, particularly for positive urgency and sensation seeking. In contrast, for CSA + AASA, higher impulsivity was associated with more positive associations across multiple impulsivity domains, including among heterosexual, gay or lesbian, and other-identified individuals. AASA showed limited moderation effects across all groups, with most interactions non-significant or inconsistent.

Country groups.

Across countries, patterns of moderation varied considerably (see Table 6). For CSA, several countries showed negative associations at higher impulsivity levels, particularly for domains such as positive urgency, sensation seeking, and negative urgency (e.g., Germany, Ireland, and Switzerland). In contrast, for CSA + AASA, a more consistent pattern emerged across countries, with higher impulsivity associated with more positive associations in countries such as the United States, Croatia, and Hungary. Moderation effects for AASA were generally inconsistent and often non-significant across countries.

Discussion

The present study offers a comprehensive examination of how impulsivity domains moderate the relationships between sexual abuse history and substance use frequency across diverse gender identities, sexual orientations, and jurisdictional contexts. Our findings extend prior research by demonstrating that impulsivity, particularly urgency facets, interact with sexual abuse history in relationships with substance use. These interactions underscore the importance of individual tendencies in understanding heterogeneous outcomes among sexual trauma survivors and align with prior work identifying impulsivity as a mechanism linking trauma to substance use [4].

Consistent with the existing literature, findings suggested that individuals higher in impulsivity, especially those with elevated negative or positive urgency, were more likely to show stronger associations between sexual abuse and substance use frequency. This aligns with prior work suggesting that impulsivity may influence substance use as a potential coping strategy for trauma-related emotional distress [3]. Urgency, which reflects tendencies to act rashly under intense emotional states, appears especially relevant for understanding maladaptive behavioral responses following trauma [9,10] and has been conceptualized as a key mechanism linking emotional states to substance use [45].

However, some results diverged from established findings. CSA was not consistently associated with higher substance use; in several groups, including cisgender women, gender-minority individuals, and certain country and sexual-orientation groups, CSA was negatively associated with substance use frequency. These results contrast with the substantial literature linking CSA to increased substance use risk [1,2]. Such discrepancies may reflect the moderating role of protective factors (e.g., resilience, social support), differential use severity, or underreporting biases, particularly in culturally or socially stigmatized settings or variation in the availability and accessibility of psychoactive substances across groups and regions. Several additional non-mutually exclusive mechanisms may account for this seemingly counterintuitive finding. First, the ASSIST-11 captures frequency of use in the past three months rather than lifetime patterns, abuse-related onset, or severity of dependence; CSA survivors who engaged in heavy substance use at an earlier developmental stage may not be in an active period of use at the time of survey completion, or their use patterns may have shifted in ways not captured by a frequency-based measure [30,35]. Second, CSA survivors may develop internalizing rather than externalizing coping styles, particularly when the abuse occurred early in development and was never disclosed, such that distress may be expressed through outcomes other than frequent substance use [3,26,46]. Third, individuals who experienced CSA without subsequent AASA may represent a relatively resilient subgroup who were able to access protective resources, such as social support or treatment [47]. Fourth, the online recruitment strategy may have underrepresented the most severely affected survivors, who may be less likely to participate in a voluntary survey. Importantly, these findings should not be interpreted as evidence that CSA is protective against substance use; the robust epidemiological literature documents positive associations between CSA and lifetime substance use risk [2], and the present cross-sectional, frequency-based findings may reflect measurement, sampling, and contextual factors rather than a true protective effect. Critically, impulsivity is not itself a coping strategy but rather a dispositional feature that may moderate in which coping behaviors individuals engage when under emotional distress [9,45]. Individuals high in urgency may be more likely to resort to substance use as a maladaptive response to trauma-related distress, a pattern more consistent with the positive moderation effects observed for AASA and CSA+AASA, where the accumulation of abuse experiences may more reliably trigger such emotion-driven substance use [12].

Importantly, the moderating effects of impulsivity domains varied by abuse type. For example, while CSA and CSA+AASA showed consistent moderation across all five UPPS-P domains, AASA demonstrated limited and inconsistent moderation effects. This suggests that impulsivity traits may exert greater influence on substance use behavior when trauma occurs earlier in life or accumulates over time. Developmental timing and chronicity of trauma may therefore shape the behavioral expression of impulsive tendencies [15,48].

Subgroup analyses suggested that gender and sexual orientation shaped associations between sexual abuse, impulsivity, and substance use frequency. Among cisgender women and gender-minority individuals, these associations were more consistently moderated by impulsivity facets. These findings align with prior research suggesting that women may be particularly vulnerable to substance use following trauma [2], and that gender-minority individuals often encounter additional stressors, including identity-related discrimination, which may intensify behavioral consequences of trauma [19,20]. Individuals identifying as gay, lesbian, or with other non-heterosexual orientations also exhibited more frequent and pronounced associations between sexual abuse, impulsivity, and substance use. These observations are consistent with the Minority Stress Model, which proposes that sexual minorities experience chronic psychosocial stress due to stigma and discrimination, contributing to elevated health risks [21,24]. When combined with documented emotional distress and difficulties in emotion regulation among sexual minority individuals generally [46], and sexual minority women specifically [49], these stressors may contribute to a heightened likelihood of substance use within these communities [50].

Jurisdictional contexts may further shape relationships. While impulsivity domains moderated the relationship between sexual abuse and substance use frequency in many countries, the pattern was more consistent in the United States, where CSA+AASA and high impulsivity jointly statistically predicted greater substance use frequency. Conversely, moderation patterns were inconsistent in countries like Belgium and the United Kingdom. These variations may reflect sociocultural differences in trauma disclosure, substance availability, stigma, mental health infrastructures, or other factors [22]. These cross-national differences highlight the importance of situating findings within specific country contexts when designing interventions [23].

Together, these findings suggest the importance of trauma-informed, culturally responsive approaches to substance use prevention and intervention. Findings suggest that clinicians should be particularly attentive to impulsivity features, especially negative and positive urgency, when working with trauma-exposed individuals. Incorporating emotion-regulation strategies into treatment (e.g., Dialectical Behavior Therapy skills such as distress tolerance and emotion regulation, or mindfulness-based relapse prevention) may be especially effective for those with high impulsivity [7]. Moreover, for sexual and gender minority populations, addressing minority stress through supportive services and affirming environments may help mitigate compounding risk factors [19,24]. These speculative possibilities warrant direct examination.

Several limitations should be considered when interpreting the findings. Although the large, diverse sample is a strength, the study is subject to both general limitations of the International Sex Survey (ISS; https://osf.io/6kscb) and issues specific to this analysis. The study’s cross-sectional design precludes causal inference. All variables were self-reported, raising concerns about recall and social desirability bias. Additionally, convergence issues during confirmatory factor analysis required us to split the country-level sample, which may reflect instability in measurement across cultural groups. A further limitation concerns the aggregation of sexual orientation categories. By grouping bisexual, pansexual, and other non-heterosexual, non-gay/lesbian identities into a single “other” category, the present analyses may obscure meaningful differences between these subgroups. Bisexual individuals, in particular, have been shown to experience elevated rates of both sexual victimization and substance use relative to gay or lesbian individuals [21]. Future studies with larger and more representative samples should examine these subgroups separately to capture potential heterogeneity in risk. Another limitation concerns the assessment of substance use, as the ASSIST-11 focuses on frequency of use but does not capture substance-related problems, consequences, or symptom severity. This limitation suggests that the findings may underestimate the clinical significance of substance-use concerns. Future research should employ longitudinal designs, include more comprehensive assessments of substance-related severity, and incorporate qualitative methods to explore the lived experiences behind these statistical associations.

Conclusions

In conclusion, this study highlights the complex interplay between sexual abuse, impulsivity, and substance use across diverse populations. By identifying specific subgroups and psychological mechanisms that shape these associations, this work contributes to a more nuanced understanding of individual and structural vulnerability and can inform more tailored, effective public health responses.

  • 24Macedonian Academy of Sciences and Arts, Republic of North Macedonia

  • 25Institute of Psychlogy, Polish Academy of Sciences, Poland

  • 28Department of Psychology, University of New Mexico, Albuquerque, USA

  • 29University of Baghdad, College of Medicine, Iraq

  • 42Chuncheon Addiction Management Center, South Korea

  • 43Centre of Excellence in Responsible Gaming, University of Gibraltar, Gibraltar

  • 52Facultad de Medicina, Universidad Científica del Sur, Lima, Perú

  • 53College of Healthcare Sciences, James Cook University, Australia

  • 54Artois University, France

  • 55Department of Psychology, Sungkyunkwan University, South Korea

Supporting information

S1 Text. Measurement invariance testing and group comparisons for CSA, AASA, and ASSIST-11.

Full narrative results of configural, metric, and scalar invariance testing and Kruskal-Wallis group comparisons by country, gender identity, and sexual orientation.

(DOCX)

pone.0355986.s001.docx (16.3KB, docx)
S2 Table. Measurement invariance results for CSA, AASA, and ASSIST-11 across 26 countries, three gender-identity groups, and three sexual-orientation groups.

Includes configural, metric, and scalar invariance fit indices, item-level details for all measurement models, and country-based pairwise comparisons from Kruskal-Wallis tests on the ASSIST-11 and SAHQ (Child, Adult, and full-scale) subscales.

(DOCX)

pone.0355986.s002.docx (210KB, docx)
S3 Table. Latent variable interaction models and simple slopes analyses for all UPPS-P impulsivity domains by abuse type (CSA, AASA, CSA+AASA) in the full sample, stratified by gender-identity group, and stratified by sexual-orientation group.

(DOCX)

pone.0355986.s003.docx (29.8KB, docx)
S4 Table. Exploratory latent variable interaction models examining lack of premeditation, lack of perseverance, and sensation seeking as moderators of abuse/substance-use associations by abuse type and demographic subgroup.

(DOCX)

pone.0355986.s004.docx (104.4KB, docx)

Acknowledgments

International Sex Survey Consortium

Lead contact: Beáta Bőthe, beata.bothe@umontreal.ca

Rafael Ballester-Arnal1, Dominik Batthyány2, Sophie Bergeron3,4, Peer Briken5, Julius Burkauskas6, Georgina Cárdenas-López7, Joana Carvalho8, Jesús Castro-Calvo9, Lijun Chen10, Giacomo Ciocca11, Ornella Corazza12,13, Rita I. Csako14, David P. Fernandez15, Elaine F. Fernandez16, Hironobu Fujiwara17,18,19, Johannes Fuss20, Roman Gabrhelík21,22, Ateret Gewirtz-Meydan23, Biljana Gjoneska24, Mateusz Gola25,26, Joshua B. Grubbs27,28, Hashim T. Hashim29,30,31, Md Saiful Islam32,33, Martha C. Jiménez-Martínez34,35, Tanja Jurin36, Ondrej Kalina37, Verena Klein38, András Költő39, Chih-Ting Lee40, Sang-Kyu Lee41,42, Karol Lewczuk43,44,45, Chung-Ying Lin46,47, Christine Lochner48, Silvia López-Alvarado49,50, Kateřina Lukavská21,51, Percy Mayta-Tristán52, Dan J. Miller53, Oľga Orosová37, Gábor Orosz54, Sungkyunkwan University’s research team*55, Fernando P. Ponce56, Gonzalo R. Quintana57, Gabriel C. Quintero Garzola58,59, Jano Ramos-Diaz60, Kévin Rigaud61, Ann Rousseau62, Marco De Tubino Scanavino63,64,65, Marion K. Schulmeyer66, Pratap Sharan67, Mami Shibata68, Sheikh Shoib69,70,71, Vera Sigre-Leirós72, Luke Sniewski73, Ognen Spasovski74, Vesta Steibliene75, Dan J. Stein76, Julian Strizek77, Banu C. Ünsal78,79,80, Marie-Pier Vaillancourt-Morel81,4, Marie Claire Van Hout82

* The Sungkyunkwan University research team includes Dr. Hyein Chang and Dr. Kyeongwoo Park.

1Departmento de Psicología Básica, Clínica y Psicobiología, University Jaume I of Castellón, Spain

2Institute for Behavioural Addictions, Sigmund Freud University Vienna, Austria

3Département de psychologie, Université de Montréal, Montréal, Canada

4Centre de recherche interdisciplinaire sur les problèmes conjugaux et les agressions sexuelles (CRIPCAS)

5Institute for Sex Research, Sexual Medicine, and Forensic Psychiatry; University Medical Centre Hamburg-Eppendorf; Hamburg, Germany

6Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, Palanga, Lithuania

7Virtual Teaching and Cyberpsychology Laboratory, School of Psychology, National Autonomous University of Mexico, Mexico

8William James Center for Research, Departamento de Educação e Psicologia, Universidade de Aveiro, Aveiro, Portugal

9Department of Personality, Assessment, and Psychological Treatments, University of Valencia, Spain

10Department of Psychology, College of Humanity and Social Science, Fuzhou University, China

11Section of Sexual Psychopathology, Department of Dynamic and Clinical Psychology, and Health Studies, Sapienza University of Rome, Rome, Italy

12Department of Clinical, Pharmaceutical and Biological Sciences, University of Hertfordshire, United Kingdom

13Department of Psychology and Cognitive Science, University of Trento, Italy

14Department of Psychology and Neuroscience, Auckland University of Technology, Auckland, New Zealand

15Department of Psychology, Nottingham Trent University, United Kingdom

16HELP University, Malaysia

17Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 18Decentralized Big Data Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan, 19The General Research Division, Osaka University Research Center on Ethical, Legal and Social Issues, Osaka, Japan

20Institute of Forensic Psychiatry and Sex Research, Center for Translational Neuro- and Behavioral Sciences, University of Duisburg-Essen, Essen, Germany

21Charles University, First Faculty of Medicine, Department of Addictology, Prague, Czech Republic

22General University Hospital in Prague, Department of Addictology, Czech Republic

23School of Social Work, Faculty of Social Welfare and Health Sciences, University of Haifa, Israel

26Institute for Neural Computations, University of California San Diego, USA

27Center on Alcohol, Substance use, And Addictions University of New Mexico, Albuquerque, USA

30University of Warith Al-Anbiyaa, College of Medicine, Karbala, Iraq

31Al-Nassiryah teaching hospital, Nassiryah, Iraq

32Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh

33Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA

34Universidad Pedagógca y Tecnológica de Colombia, Colombia

35Escuela de Psicologia

36Department of Psychology, Humanities and Social Sciences, University of Zagreb, Croatia

37Department of Educational Psychology and Psychology of Health, Pavol Jozef Safarik University in Kosice, Slovakia

38School of Psychology, University of Southampton, United Kingdom

39Health Promotion Research Centre, University of Galway, Ireland

40Department of Family Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

41Department of Psychiatry, Hallym University Chuncheon Sacred Heart Hospital, South Korea

44Institute of Psychology, Cardinal Stefan Wyszynski University, Warsaw, Poland

45Department of Psychology, University of Nevada, Las Vegas, Las Vegas, NV, USA

46Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

47Biostatistics Consulting Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

48SAMRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry, Stellenbosch University, South Africa

49Faculty of Psychology, University of Cuenca, Ecuador

50Department of Education, University of Cuenca, Ecuador

51Charles University, Faculty of Education, Department of Psychology, Prague, Czech Republic

56Departamento de Psicología, Universidad Católica del Maule

57Departamento de Psicología, Facultad de Ciencias Sociales, Universidad de Chile, Santiago, Chile

58Florida State University, Republic of Panama

59Sistema Nacional de Investigación (SNI), SENACYT, Panama

60Facultad de Ciencias de la Salud, Universidad Privada del Norte, Lima, Perú

61Picardie Jules Verne University, France

62Leuven School For Mass Communication, KU Leuven, Leuven, Belgium

63Department of Psychiatry, Schulich School of Medicine & Dentistry, Western University, London Health Sciences Centre and St. Joseph’s Health Care London. London, ON, Canada. Lawson Research Institute and London Health Sciences Centre Research Institute, London, Ontario, Canada.

64Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, Hospital das Clinicas, Instituto de Psiquiatria, Excessive Sexual Drive and Prevention of Negative Outcomes associated to Sexual Behavior Outpatient Unit (AISEP), Brazil.

65Experimental Pathophisiology Post Graduation Program, Faculdade de Medicina, Universidade de São Paulo, Brazil

66Universidad Privada de Santa Cruz de la Sierra, Bolivia

67Department of Psychiatry, All India Institute of Medical Sciences, New Delhi −110029, India

68Department of Neuropsychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan

69Department of Psychology, Shardha University, India

70Department of Health Services, Srinagar, 190001 India

71Psychosis Research Centre, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

72Institute of Psychology, University of Lausanne, Lausanne, Switzerland

73Compassionate Inquiry, Canada

74Faculty of Arts, University of Ss. Cyril and Methodius in Trnava, Slovakia

75Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health sciences, Palanga, Lithuania

76SAMRC Unit on Risk & Resilience in Mental Disorders, Dept of Psychiatry & Neuroscience Institute, University of Cape Town

77Austrian Public Health Institute, Austria

78Amsterdam University Medical Centers, Center of Expertise on Gender Dysphoria, Amsterdam, The Netherlands

79Doctoral School of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary

80Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary

81Département de Psychologie, Université du Québec à Trois-Rivières, Trois-Rivières, Canada

82Office of the VP Research, Innovation and Impact, South East Technological University, Ireland

Data Availability

Due to ethical constraints the authors are not able to share the data underlying their study publicly. The multi-national International Sex Survey (ISS) dataset spans 42 countries and was collected across more than 50 institutions; therefore, no single institutional repository is designated or available. Dr. Marie-Alexia Masella (marie-alexia.masella@umontreal.ca) at the University of Montreal may be contacted with requests for access to these data.

Funding Statement

Financial Disclosure Statement The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Damla Aksen DEA was supported by the NIDA T32 Neuroimaging Sciences Training in Substance Abuse Program (T32DA022975), Sarah Lichenstein SL was supported by K08DA051667 Beáta Bőthe BB was supported by the FRQSC – Research Support for New Academics (NP) Program (https://doi.org/10.69777/343918). BB is a researcher of the Centre de Recherche Interdisciplinaire sur les Problèmes Conjugaux et les Agressions Sexuelles, supported by the FRQSC - Regroupements stratégiques / Centre - fonctionnement (https://doi.org/10.69777/281155). Léna Nagy LN was supported by the ÚNKP-22-3 and ÚNKP-23-4 New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund. Shane Kraus SWK was supported by the Kindbridge Research Institute. Zsolt Demetrovics ZD was supported by the Hungarian National Research, Development, and Innovation Office (Grant numbers: KKP126835). Joël Billieux JB received support from the WUN Research Development Fund (RDF) 2021.

References

  • 1.Fergusson DM, McLeod GFH, Horwood LJ. Childhood sexual abuse and adult developmental outcomes: findings from a 30-year longitudinal study in New Zealand. Child Abuse Negl. 2013;37(9):664–74. doi: 10.1016/j.chiabu.2013.03.013 [DOI] [PubMed] [Google Scholar]
  • 2.Simpson TL, Miller WR. Concomitance between childhood sexual and physical abuse and substance use problems. A review. Clin Psychol Rev. 2002;22(1):27–77. doi: 10.1016/s0272-7358(00)00088-x [DOI] [PubMed] [Google Scholar]
  • 3.Weiss NH, Tull MT, Lavender J, Gratz KL. Role of emotion dysregulation in the relationship between childhood abuse and probable PTSD in a sample of substance abusers. Child Abuse Negl. 2013;37(11):944–54. doi: 10.1016/j.chiabu.2013.03.014 [DOI] [PubMed] [Google Scholar]
  • 4.Oshri A, Kogan SM, Kwon JA, Wickrama KAS, Vanderbroek L, Palmer AA, et al. Impulsivity as a mechanism linking child abuse and neglect with substance use in adolescence and adulthood. Dev Psychopathol. 2018;30(2):417–35. doi: 10.1017/S0954579417000943 [DOI] [PubMed] [Google Scholar]
  • 5.Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158(11):1783–93. doi: 10.1176/appi.ajp.158.11.1783 [DOI] [PubMed] [Google Scholar]
  • 6.de Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol. 2009;14(1):22–31. doi: 10.1111/j.1369-1600.2008.00129.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32(4):777–810. doi: 10.1016/j.neubiorev.2007.11.003 [DOI] [PubMed] [Google Scholar]
  • 8.Whiteside SP, Lynam DR. The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity. Pers Individ Differ. 2001;30(4):669–89. doi: 10.1016/s0191-8869(00)00064-7 [DOI] [Google Scholar]
  • 9.Cyders MA, Smith GT. Emotion-based dispositions to rash action: positive and negative urgency. Psychol Bull. 2008;134(6):807–28. doi: 10.1037/a0013341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Berg JM, Latzman RD, Bliwise NG, Lilienfeld SO. Parsing the heterogeneity of impulsivity: A meta-analytic review of the behavioral implications of the UPPS for psychopathology. Psychol Assess. 2015;27(4):1129–46. doi: 10.1037/pas0000111 [DOI] [PubMed] [Google Scholar]
  • 11.Karyadi KA, King KM. Urgency and negative emotions: Evidence for moderation on negative alcohol consequences. Pers Individ Differ. 2011;51(5):635–40. doi: 10.1016/j.paid.2011.05.030 [DOI] [Google Scholar]
  • 12.al’Absi M, DeAngelis B, Borodovsky J, Sofis MJ, Fiecas M, Budney A. Early life adversity and substance use: The mediating role of mood and the moderating role of impulsivity. J Psychiatr Res. 2023;168:38–44. doi: 10.1016/j.jpsychires.2023.10.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Settles RF, Cyders M, Smith GT. Longitudinal validation of the acquired preparedness model of drinking risk. Psychol Addict Behav. 2010;24(2):198–208. doi: 10.1037/a0017631 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kim JH, Choi JY. Influence of childhood trauma and post-traumatic stress symptoms on impulsivity: focusing on differences according to the dimensions of impulsivity. Eur J Psychotraumatol. 2020;11(1):1796276. doi: 10.1080/20008198.2020.1796276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Felton JW, Shadur JM, Havewala M, Gonçalves S, Lejuez CW. Impulsivity Moderates the Relation between Depressive Symptoms and Substance Use across Adolescence. J Clin Child Adolesc Psychol. 2020;49(3):365–77. doi: 10.1080/15374416.2018.1537189 [DOI] [PubMed] [Google Scholar]
  • 16.Arwood Z, Nooner KB. Adverse Childhood Experiences and Binge Drinking in Adolescence: the Role of Impulsivity and PTSD Symptoms. J Pediatr Neuropsychol. 2023;9(1):30–41. doi: 10.1007/s40817-022-00135-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Burlew AK, Weekes JC, Montgomery L, Feaster DJ, Robbins MS, Rosa CL, et al. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network. Am J Drug Alcohol Abuse. 2011;37(5):324–32. doi: 10.3109/00952990.2011.596973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lehavot K, Simoni JM. The impact of minority stress on mental health and substance use among sexual minority women. J Consult Clin Psychol. 2011;79(2):159–70. doi: 10.1037/a0022839 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hughto JMW, Quinn EK, Dunbar MS, Rose AJ, Shireman TI, Jasuja GK. Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses Among US Transgender and Cisgender Adults. JAMA Netw Open. 2021;4(2):e2036512. doi: 10.1001/jamanetworkopen.2020.36512 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Testa RJ, Michaels MS, Bliss W, Rogers ML, Balsam KF, Joiner T. Suicidal ideation in transgender people: Gender minority stress and interpersonal theory factors. J Abnorm Psychol. 2017;126(1):125–36. doi: 10.1037/abn0000234 [DOI] [PubMed] [Google Scholar]
  • 21.Coulter RWS, Bersamin M, Russell ST, Mair C. The Effects of Gender- and Sexuality-Based Harassment on Lesbian, Gay, Bisexual, and Transgender Substance Use Disparities. J Adolesc Health. 2018;62(6):688–700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Harris MG, Bharat C, Glantz MD, Sampson NA, Al-Hamzawi A, Alonso J, et al. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. Addiction. 2019;114(8):1446–59. doi: 10.1111/add.14599 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Amaro H, Sanchez M, Bautista T, Cox R. Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism. Neuropharmacology. 2021;188:108518. doi: 10.1016/j.neuropharm.2021.108518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003;129(5):674–97. doi: 10.1037/0033-2909.129.5.674 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31. doi: 10.1016/j.socscimed.2015.11.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Settles RE, Fischer S, Cyders MA, Combs JL, Gunn RL, Smith GT. Negative urgency: a personality predictor of externalizing behavior characterized by neuroticism, low conscientiousness, and disagreeableness. J Abnorm Psychol. 2012;121(1):160–72. doi: 10.1037/a0024948 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bothe B, Koos M, Nagy L, Kraus SW, Potenza MN, Demetrovics Z. International Sex Survey: Study protocol of a large, cross-cultural collaborative study in 45 countries. J Behav Addict. 2021;10(3):632–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fournier L, Bőthe B, Demetrovics Z, Koós M, Kraus SW, Nagy L, et al. Evaluating the factor structure and measurement invariance of the 20-item short version of the UPPS-P Impulsive Behavior Scale across multiple countries, languages, and gender identities. Assessment. 2025;32(5):635–53. doi: 10.1177/10731911241259560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Horváth Z, Nagy L, Koós M, Kraus SW, Demetrovics Z, Potenza MN, et al. Psychometric properties of the Alcohol Use Disorders Identification Test (AUDIT) across cross-cultural subgroups, genders, and sexual orientations: Findings from the International Sex Survey (ISS). Compr Psychiatry. 2023;127:152427. doi: 10.1016/j.comppsych.2023.152427 [DOI] [PubMed] [Google Scholar]
  • 30.Lee C-T, Lin C-Y, Koós M, Nagy L, Kraus SW, Demetrovics Z, et al. The eleven-item Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-11): Cross-cultural psychometric evaluation across 42 countries. J Psychiatr Res. 2023;165:16–27. doi: 10.1016/j.jpsychires.2023.06.033 [DOI] [PubMed] [Google Scholar]
  • 31.Nagy L, Bergeron S, Koós M, Gewirtz-Meydan A, Vaillancourt-Morel M-P, Kraus SW, et al. A short screen for lifetime sexual victimization experiences: Expanding research on the Sexual Abuse History Questionnaire (SAHQ) across cultures, genders, and sexual identities. Int J Clin Health Psychol. 2025;25(1):100535. doi: 10.1016/j.ijchp.2024.100535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Leserman J, Drossman DA, Li Z. The reliability and validity of a sexual and physical abuse history questionnaire in female patients with gastrointestinal disorders. Behav Med. 1995;21(3):141–50. doi: 10.1080/08964289.1995.9933752 [DOI] [PubMed] [Google Scholar]
  • 33.Billieux J, Rochat L, Ceschi G, Carré A, Offerlin-Meyer I, Defeldre A-C, et al. Validation of a short French version of the UPPS-P Impulsive Behavior Scale. Compr Psychiatry. 2012;53(5):609–15. doi: 10.1016/j.comppsych.2011.09.001 [DOI] [PubMed] [Google Scholar]
  • 34.Cyders MA, Littlefield AK, Coffey S, Karyadi KA. Examination of a short English version of the UPPS-P Impulsive Behavior Scale. Addict Behav. 2014;39(9):1372–6. doi: 10.1016/j.addbeh.2014.02.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94. doi: 10.1046/j.1360-0443.2002.00185.x [DOI] [PubMed] [Google Scholar]
  • 36.Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, et al. Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST). Addiction. 2008;103(6):1039–47. doi: 10.1111/j.1360-0443.2007.02114.x [DOI] [PubMed] [Google Scholar]
  • 37.Newcombe DA, Humeniuk RE, Ali R. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005;24(3):217–26. doi: 10.1080/09595230500170266 [DOI] [PubMed] [Google Scholar]
  • 38.Browne MW, Cudeck R. Alternative Ways of Assessing Model Fit. Sociol Methods Res. 1992;21(2):230–58. doi: 10.1177/0049124192021002005 [DOI] [Google Scholar]
  • 39.Chen F, Curran PJ, Bollen KA, Kirby J, Paxton P. An Empirical Evaluation of the Use of Fixed Cutoff Points in RMSEA Test Statistic in Structural Equation Models. Sociol Methods Res. 2008;36(4):462–94. doi: 10.1177/0049124108314720 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kenny DA, Kaniskan B, McCoach DB. The Performance of RMSEA in Models With Small Degrees of Freedom. Sociol Methods Res. 2014;44(3):486–507. doi: 10.1177/0049124114543236 [DOI] [Google Scholar]
  • 41.Marsh HW, Guo J, Dicke T, Parker PD, Craven RG. Confirmatory Factor Analysis (CFA), Exploratory Structural Equation Modeling (ESEM), and Set-ESEM: Optimal Balance Between Goodness of Fit and Parsimony. Multivariate Behav Res. 2020;55(1):102–19. [DOI] [PubMed] [Google Scholar]
  • 42.Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: Tests of significance and descriptive goodness-of-fit measures. Methods Psychol Res-Online. 2003;8(2):23–74. [Google Scholar]
  • 43.Svetina D, Rutkowski L. Multidimensional Measurement Invariance in an International Context: Fit Measure Performance With Many Groups. J Cross-Cult Psychol. 2017;48(7):991–1008. doi: 10.1177/0022022117717028 [DOI] [Google Scholar]
  • 44.Svetina D, Rutkowski L, Rutkowski D. Multiple-Group Invariance with Categorical Outcomes Using Updated Guidelines: An Illustration Using M plus and the lavaan/semTools Packages. Struct Equ Modeling. 2019;27(1):111–30. doi: 10.1080/10705511.2019.1602776 [DOI] [Google Scholar]
  • 45.Smith GT, Cyders MA. Integrating affect and impulsivity: The role of positive and negative urgency in substance use risk. Drug Alcohol Depend. 2016;163 Suppl 1(Suppl 1):S3–12. doi: 10.1016/j.drugalcdep.2015.08.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hatzenbuehler ML, McLaughlin KA, Nolen-Hoeksema S. Emotion regulation and internalizing symptoms in a longitudinal study of sexual minority and heterosexual adolescents. J Child Psychol Psychiatry. 2008;49(12):1270–8. doi: 10.1111/j.1469-7610.2008.01924.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Bulik CM, Prescott CA, Kendler KS. Features of childhood sexual abuse and the development of psychiatric and substance use disorders. Br J Psychiatry. 2001;179:444–9. doi: 10.1192/bjp.179.5.444 [DOI] [PubMed] [Google Scholar]
  • 48.Bountress K, Adams ZW, Gilmore AK, Amstadter AB, Thomas S, Danielson CK. Associations among impulsivity, trauma history, and alcohol misuse within a young adult sample. Addict Behav. 2017;64:179–84. doi: 10.1016/j.addbeh.2016.08.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Fitzpatrick S, Dworkin ER, Zimmerman L, Javorka M, Kaysen D. Stressors and Drinking in Sexual Minority Women: The Mediating Role of Emotion Dysregulation. Psychol Sex Orientat Gend Divers. 2020;7(1):46–54. doi: 10.1037/sgd0000351 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Marshal MP, Friedman MS, Stall R, King KM, Miles J, Gold MA, et al. Sexual orientation and adolescent substance use: a meta-analysis and methodological review. Addiction. 2008;103(4):546–56. doi: 10.1111/j.1360-0443.2008.02149.x [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Jennifer Tucker

17 May 2026

Dear Dr. Potenza,

Please submit your revised manuscript by Jun 28 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Jennifer Tucker, PhD

Staff Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following financial disclosure:

“Financial Disclosure Statement

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Damla Aksen

DEA was supported by the NIDA T32 Neuroimaging Sciences Training in Substance Abuse Program (T32DA022975), and K08DA051667

Beáta Bőthe

BB was supported by the FRQSC – Research Support for New Academics (NP) Program (https://doi.org/10.69777/343918). BB is a researcher of the Centre de Recherche Interdisciplinaire sur les Problèmes Conjugaux et les Agressions Sexuelles, supported by the FRQSC - Regroupements stratégiques / Centre - fonctionnement (https://doi.org/10.69777/281155).

Léna Nagy

LN was supported by the ÚNKP-22-3 and ÚNKP-23-4 New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund.

Shane Kraus

SWK was supported by the Kindbridge Research Institute.

Zsolt Demetrovics

ZD was supported by the Hungarian National Research, Development, and Innovation Office (Grant numbers: KKP126835).

Joël Billieux

JB received support from the WUN Research Development Fund (RDF) 2021”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. In the online submission form, you indicated that your data is available only on request from a third party. Please note that your Data Availability Statement is currently missing the name of the third party contact or institution / contact details for the third party, such as an email address or a link to where data requests can be made. Please update your statement with the missing information.

5. One of the noted authors is a group or consortium “International Sex Survey Consortium” In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

6. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

8. We note that there is identifying data in the Supporting Information file “Aksen_ISS_ASSIST11_supplement.docx” Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws.

Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared:

-Name, initials, physical address

-Ages more specific than whole numbers

-Internet protocol (IP) address

-Specific dates (birth dates, death dates, examination dates, etc.)

-Contact information such as phone number or email address

-Location data

-ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order)

Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants.

Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long

Please remove or anonymize all personal information (<specific identifying information in file to be removed>), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.

9. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

10. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible.

[Note: HTML markup is below. Please do not edit.]

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: This is a very well written article that examines the association between sexual abuse and substance use frequency, examining impulsivity as a moderator. Before publication, however, the following should be addressed:

• Please provide a rationale for why only 3 categories were used for sexual orientation. Bisexual youth often have higher risk behaviors, so it is unclear why other categories for sexual orientation were not included. If the authors are unable to delineate additional categories, this should be noted in the limitations section.

• Table 2 – please provide footnotes that inform the reader how to interpret the scores; the tables should be standalone from the text

• For the SUPPS-P – please provide an example item for each “facet” of impulsivity; please also provide scoring instructions

• More explanation is needed for why CSA was associated with lower levels of substance use frequency. The authors seem to “gloss” over this a bit in their discussion. For example, the authors mention that impulsivity might be a coping strategy – but how can it be a coping strategy if substance use frequency is increasing.

**********

what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Sep 30;21(9):e0355986. doi: 10.1371/journal.pone.0355986.r002

Author response to Decision Letter 1


9 Jul 2026

Re: PONE-D-26-01923 – Response to Reviewers and Revised Manuscript

Dear Dr. Tucker and Editorial Board,

We thank the editors and the reviewer for their careful and constructive evaluation of our manuscript, “The Moderating Role of Impulsivity in the Association between Sexual Abuse and Substance Use Frequency across Countries, Gender Identities, and Sexual Orientations.” We have addressed all points raised and provide detailed responses below. All changes to the manuscript are reflected in the Revised Manuscript with Track Changes file.

RESPONSES TO JOURNAL REQUIREMENTS

Requirement 1: PLOS ONE Style Requirements

We have reviewed the manuscript against the PLOS ONE style templates and made necessary formatting adjustments to ensure compliance with heading levels, in-text citation style, and file naming conventions.

Requirement 2: Grant Numbers – Funding Information vs. Financial Disclosure

We have verified the grant numbers in the Financial Disclosure Statement and confirm these are the correct awards received. The corresponding author (Dr. Potenza) has updated the Funding Information fields in the Editorial Manager submission portal to match the Financial Disclosure Statement exactly. The confirmed grants are:

DEA: T32DA022975 and K08DA051667

BB: FRQSC NP Program (https://doi.org/10.69777/343918) and FRQSC Regroupements stratégiques (https://doi.org/10.69777/281155)

LN: ÚNKP-22-3 and ÚNKP-23-4

SWK: Kindbridge Research Institute

ZD: KKP126835

JB: WUN Research Development Fund (RDF) 2021

Requirement 3: Role of Funder Statement

We confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This statement is included in the Financial Disclosure Statement document and is reproduced here for the editorial team to update in the online submission form:

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Requirement 4: Data Availability Statement – Third-Party Contact

We have updated the Data Sharing Statement to include the contact information for data access requests. The updated statement now reads in full:

We believe that openly sharing data is important for replication purposes, and in general, we apply this open science practice in our work. However, in this case, it is unfortunately not possible due to ethical constraints. A total of 42 countries are involved in the International Sex Survey, of which 26 are included in the present study. The project was approved by the national or institutional ethics review boards of all participating countries, or, in some cases, the local ethics committees deemed the study exempt from further review, as it had already received approval from the principal investigators’ institutions (https://osf.io/n3k2c/files/osfstorage/636974c6f490ee001cfe45fe). Participating countries and institutions have different ethical regulations regarding data sharing, especially when the dataset includes sensitive topics (e.g., sexuality, pornography use, religiosity). While some institutions support open data sharing, others restrict it to protect participants. As the project aimed to follow a standardized protocol across all participating countries, we adopted the most stringent approach to data sharing (i.e., not sharing the data publicly but instead providing access upon request). Furthermore, based on consultation with a member of the institutional ethics review board at the first author’s institution, public data sharing would require participants’ explicit consent. However, this consent was not included in the original informed consent form, and it is not possible to obtain it retrospectively, as the data were collected anonymously. Requests for data access may be directed to the lead investigator of the International Sex Survey, Beáta Bőthe (beata.bothe@umontreal.ca).

The corresponding author has also updated this statement in the Editorial Manager submission portal.

Requirement 5: ISS Consortium – Lead Contact and Individual Members

The full membership list of the International Sex Survey Consortium with institutional affiliations was already present in the Acknowledgments section of the manuscript. We have added a lead contact line at the top of the Consortium listing in the Acknowledgments (see tracked changes): “Lead contact: Beáta Bőthe, beata.bothe@umontreal.ca.”

Requirement 6: Full Ethics Statement in Methods

We have expanded the ethics statement in the Methods section (Procedure subsection) to include the full names of the relevant ethics committees and to confirm the consent procedure. Specifically, we now state that ethics approval in Canada was granted by the Comité d’éthique de la recherche of the Université du Québec à Trois-Rivières (CER-21-276-07.03) and the Comité d’éthique de la recherche en éducation et en psychologie of the Université de Montréal (CEREP, project #2021-2877), and that all participants provided written informed consent electronically prior to completing the survey. A complete list of ethics approvals by country is available at the OSF project page (https://osf.io/n3k2c/files/osfstorage/636974c6f490ee001cfe45fe). Please see the tracked changes in the revised manuscript.

Requirement 7: Supporting Information Captions

Captions for all Supporting Information files have been added at the end of the manuscript under a “Supporting Information” heading. In-text citations are consistent with these captions. Please see the tracked changes in the revised manuscript.

Requirement 8: Identifying Data in Supplemental File

We thank the editorial team for flagging this. Upon careful review of the supplemental file, we confirmed that it contains only aggregate-level statistical output, specifically, measurement invariance model fit indices (CFI, TLI, RMSEA, chi-square values) across country, gender identity, and sexual orientation groups. There is no participant-level data, no names, no IP addresses, no specific dates, no contact information, and no ID numbers in the file. We have re-uploaded the file and respectfully request that the editorial team clarify what specific information was flagged, as we were unable to identify any identifying information in the document.

Requirement 9: Reviewer-Recommended Citations

We have added Coulter et al. (2018) to the Limitations section in response to the bisexual subgroup comment, and all other new citations were added based on the substantive content of our revisions.

Requirement 10: Reference List Review

We have reviewed all references for completeness and accuracy. No retracted articles were identified. All references have been verified and corrected where necessary.

RESPONSES TO REVIEWER #1 COMMENTS

We sincerely thank Reviewer #1 for their thoughtful feedback. Reviewer comments are shown in italics; our responses follow.

Comment 1: Rationale for Three Sexual Orientation Categories

“Please provide a rationale for why only 3 categories were used for sexual orientation. Bisexual youth often have higher risk behaviors, so it is unclear why other categories for sexual orientation were not included. If the authors are unable to delineate additional categories, this should be noted in the limitations section.”

Response: We thank the reviewer for this important point. The three-category grouping (heterosexual, gay or lesbian, and other sexual orientations) was necessary to maintain adequate cell sizes for stable structural equation modeling. The ‘other’ category includes bisexual, pansexual, asexual, queer, and other non-heterosexual, non-gay/lesbian identities. The original preregistration specified eight sexual orientation categories, but several had insufficient sample sizes for reliable model estimation. We have added an explicit rationale for this grouping in the Methods section (Sociodemographic Characteristics subsection) and have added a new limitation paragraph acknowledging that this aggregation may obscure meaningful differences between bisexual individuals and other sexual minority subgroups, with reference to Coulter et al. (2018). Please see the tracked changes.

Comment 2: Table 2 Footnotes

“Table 2 – please provide footnotes that inform the reader how to interpret the scores; the tables should be standalone from the text.”

Response: We agree. The Table 2 note has been substantially expanded to include: the ASSIST-11 score range (0–40) and interpretation of higher scores; each UPPS-P subscale’s item count (4 items) and range (4–16); a statement that higher scores reflect greater impulsivity on all subscales; and a description of the 4-point Likert scale and reverse-coding procedure. Table 2 is now fully interpretable without reference to the main text. Please see the tracked changes.

Comment 3: SUPPS-P Example Items and Scoring

“For the SUPPS-P – please provide an example item for each ‘facet’ of impulsivity; please also provide scoring instructions.”

Response: We have expanded the SUPPS-P description in the Measures section to include one labeled example item per facet: Lack of Premeditation (“I usually think carefully before doing anything” [reverse-coded]); Lack of Perseverance (“I finish what I start” [reverse-coded]); Sensation Seeking (“I welcome new and exciting experiences and sensations, even if they are a little frightening or unconventional”); Negative Urgency (“When I feel bad, I often do things I later regret”); and Positive Urgency (“When I’m in a great mood, I tend to get carried away easily”). We have also clarified the reverse-coding procedure and stated that subscale scores range from 4 to 16, with higher scores uniformly reflecting greater impulsivity. Please see the tracked changes.

Comment 4: CSA and Lower Substance Use Frequency

“More explanation is needed for why CSA was associated with lower levels of substance use frequency. The authors seem to ‘gloss’ over this a bit in their discussion. For example, the authors mention that impulsivity might be a coping strategy – but how can it be a coping strategy if substance use frequency is increasing.”

Response: We thank the reviewer for this close reading and fully agree this finding warranted more substantive engagement. We have substantially expanded the relevant Discussion paragraph to address both points. First, we clarify that impulsivity is not itself a coping strategy but rather a dispositional feature that moderates which coping behaviors individuals engage in under emotional distress; individuals high in urgency may be more likely to resort to substance use as a maladaptive response to trauma-related distress, which is consistent with the positive moderation effects observed for AASA and CSA+AASA. Second, we offer four non-mutually exclusive mechanistic explanations for the negative CSA-substance use association: (1) the ASSIST-11 captures only past-3-month frequency rather than lifetime patterns or severity; (2) CSA survivors may develop internalizing rather than externalizing coping styles, particularly when abuse occurred early and was never disclosed; (3) those who experienced CSA without subsequent AASA may represent a relatively resilient subgroup who accessed protective resources; and (4) online recruitment may have underrepresented the most severely affected survivors. We also explicitly note that these findings should not be interpreted as evidence that CSA is protective against substance use. Please see the tracked changes.

Attachment

Submitted filename: Response_to_Reviewers.docx

pone.0355986.s006.docx (19.2KB, docx)

Decision Letter 1

Emily Lund

28 Jul 2026

The Moderating Role of Impulsivity in the Association between Sexual Abuse and Substance Use Frequency across Countries, Gender Identities, and Sexual Orientations

PONE-D-26-01923R1

Dear Dr. Potenza,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Emily Lund

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Emily Lund

PONE-D-26-01923R1

PLOS One

Dear Dr. Potenza,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS One and supporting open access.

Kind regards,

PLOS One Editorial Office Staff

on behalf of

Dr. Emily Lund

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Measurement invariance testing and group comparisons for CSA, AASA, and ASSIST-11.

    Full narrative results of configural, metric, and scalar invariance testing and Kruskal-Wallis group comparisons by country, gender identity, and sexual orientation.

    (DOCX)

    pone.0355986.s001.docx (16.3KB, docx)
    S2 Table. Measurement invariance results for CSA, AASA, and ASSIST-11 across 26 countries, three gender-identity groups, and three sexual-orientation groups.

    Includes configural, metric, and scalar invariance fit indices, item-level details for all measurement models, and country-based pairwise comparisons from Kruskal-Wallis tests on the ASSIST-11 and SAHQ (Child, Adult, and full-scale) subscales.

    (DOCX)

    pone.0355986.s002.docx (210KB, docx)
    S3 Table. Latent variable interaction models and simple slopes analyses for all UPPS-P impulsivity domains by abuse type (CSA, AASA, CSA+AASA) in the full sample, stratified by gender-identity group, and stratified by sexual-orientation group.

    (DOCX)

    pone.0355986.s003.docx (29.8KB, docx)
    S4 Table. Exploratory latent variable interaction models examining lack of premeditation, lack of perseverance, and sensation seeking as moderators of abuse/substance-use associations by abuse type and demographic subgroup.

    (DOCX)

    pone.0355986.s004.docx (104.4KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewers.docx

    pone.0355986.s006.docx (19.2KB, docx)

    Data Availability Statement

    Due to ethical constraints the authors are not able to share the data underlying their study publicly. The multi-national International Sex Survey (ISS) dataset spans 42 countries and was collected across more than 50 institutions; therefore, no single institutional repository is designated or available. Dr. Marie-Alexia Masella (marie-alexia.masella@umontreal.ca) at the University of Montreal may be contacted with requests for access to these data.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES